Page last updated: 2024-09-05

ibogaine and Opioid-Related Disorders

ibogaine has been researched along with Opioid-Related Disorders in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (10.00)	18.2507
2000's	4 (20.00)	29.6817
2010's	10 (50.00)	24.3611
2020's	4 (20.00)	2.80

Authors

Authors	Studies
Luz, M; Mash, DC	2
Belgers, M; Donders, R; Knuijver, T; Kramers, K; Schellekens, A; Verkes, RJ	1
Belgers, M; Donders, R; Knuijver, T; Kramers, K; Schellekens, A; van Oosteren, T; Verkes, R	1
Frampton, CM; Noller, GE; Yazar-Klosinski, B	1
Alper, K; Brown, TK	1
C Mash, D	1
Ameyaw, B; Farrow, SC; Kamileen, MO; Meades, J; O'Connor, SE; Xiao, Y	1
Belgers, M; Knuijver, T; Markus, W; Schellekens, A; van Oosteren, T; Verkes, RJ	1
Bussey, K; Caputi, L; Farrow, SC; Kamileen, MO; McAtee, RC; Mundy, JEA; O'Connor, SE; Stephenson, CRJ	1
Willyard, C	1
Cape, G; Devane, J; Friedhoff, L; Glue, P; Gray, A; Harland, S; Howes, J; Hung, CT; Hung, N; Lam, F; Lockhart, M; Tunnicliff, D; Weis, H	1
Cape, G; Crockett, RS; Darpo, B; Devane, J; Friedhoff, L; Glue, P; Harland, S; Howes, J; Hung, CT; Hung, N; Lam, F; Lockhart, M; Tunnicliff, D; Weis, H; Zhou, M	1
Gevirtz, C	1
Alper, KR; Glick, SD	1
Daley, M; Fuller, BE; McCarty, D; Rieckmann, T; Thomas, CP	1
Alper, KR; Kaplan, CD; Lotsof, HS	1
Bandarage, UK; Glick, SD; Kuehne, ME; Maisonneuve, IM; Molinari, HH	1
Badio, B; Daly, JW; Padgett, WL	1
Ali, SF; Baumann, MH; Mash, DC; Pablo, J; Rothman, RB	1

Reviews

2 review(s) available for ibogaine and Opioid-Related Disorders

Article	Year
Anesthesia for opiate detoxification and the ibogaine controversy. International anesthesiology clinics, 2011,Winter, Volume: 49, Issue:1 Topics: Anesthesia; Animals; Humans; Ibogaine; Opioid-Related Disorders	2011
Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine. The Alkaloids. Chemistry and biology, 2001, Volume: 56 Topics: Animals; Behavior, Animal; Brain; Corticosterone; Dopamine; Humans; Ibogaine; Opioid-Related Disorders; Serotonin	2001

Trials

2 trial(s) available for ibogaine and Opioid-Related Disorders

Article	Year
Switching Opioid-Dependent Patients From Methadone to Morphine: Safety, Tolerability, and Methadone Pharmacokinetics. Journal of clinical pharmacology, 2016, Volume: 56, Issue:8 Topics: Adult; Analgesics, Opioid; Double-Blind Method; Drug Substitution; Female; Headache; Humans; Ibogaine; Male; Methadone; Morphine; Nausea; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome	2016
Ascending Single-Dose, Double-Blind, Placebo-Controlled Safety Study of Noribogaine in Opioid-Dependent Patients. Clinical pharmacology in drug development, 2016, Volume: 5, Issue:6 Topics: Adult; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Ibogaine; Long QT Syndrome; Male; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome	2016

Article

Year

Switching Opioid-Dependent Patients From Methadone to Morphine: Safety, Tolerability, and Methadone Pharmacokinetics.

Journal of clinical pharmacology, 2016, Volume: 56, Issue:8

Topics: Adult; Analgesics, Opioid; Double-Blind Method; Drug Substitution; Female; Headache; Humans; Ibogaine; Male; Methadone; Morphine; Nausea; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome

2016

Ascending Single-Dose, Double-Blind, Placebo-Controlled Safety Study of Noribogaine in Opioid-Dependent Patients.

Clinical pharmacology in drug development, 2016, Volume: 5, Issue:6

Topics: Adult; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Ibogaine; Long QT Syndrome; Male; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome

2016

Other Studies

16 other study(ies) available for ibogaine and Opioid-Related Disorders

Article	Year
Reply to Knuijver et al. on the 'Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study'. Addiction (Abingdon, England), 2022, Volume: 117, Issue:3 Topics: Analgesics, Opioid; Humans; Ibogaine; Opioid-Related Disorders; Substance Withdrawal Syndrome	2022
Response to Luz & Mash on cardiac toxicity of ibogaine. Addiction (Abingdon, England), 2022, Volume: 117, Issue:3 Topics: Cardiotoxicity; Hallucinogens; Humans; Ibogaine; Opioid-Related Disorders	2022
Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study. Addiction (Abingdon, England), 2022, Volume: 117, Issue:1 Topics: Analgesics, Opioid; Data Collection; Humans; Ibogaine; Morphine; Opioid-Related Disorders	2022
Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse. Expert opinion on drug metabolism & toxicology, 2021, Volume: 17, Issue:9 Topics: Animals; Hallucinogens; Humans; Ibogaine; Opioid-Related Disorders	2021
Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. The American journal of drug and alcohol abuse, 2018, Volume: 44, Issue:1 Topics: Adult; Depression; Female; Follow-Up Studies; Hallucinogens; Humans; Ibogaine; Male; Middle Aged; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome	2018
Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes. The American journal of drug and alcohol abuse, 2018, Volume: 44, Issue:1 Topics: Adult; Female; Hallucinogens; Humans; Ibogaine; Male; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult	2018
Breaking the cycle of opioid use disorder with Ibogaine. The American journal of drug and alcohol abuse, 2018, Volume: 44, Issue:1 Topics: Humans; Ibogaine; Opioid-Related Disorders	2018
Cytochrome P450 and The Journal of biological chemistry, 2018, 09-07, Volume: 293, Issue:36 Topics: Alkaloids; Catalysis; Cytochrome P-450 Enzyme System; High-Throughput Nucleotide Sequencing; Ibogaine; Opioid-Related Disorders; Protein O-Methyltransferase; Tabernaemontana; Transcriptome	2018
Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence. Journal of clinical psychopharmacology, 2018, Volume: 38, Issue:6 Topics: Adult; Hallucinogens; Humans; Ibogaine; Male; Opioid-Related Disorders; Perceptual Disorders; Time Factors	2018
Biosynthesis of an Anti-Addiction Agent from the Iboga Plant. Journal of the American Chemical Society, 2019, 08-21, Volume: 141, Issue:33 Topics: Biosynthetic Pathways; Humans; Ibogaine; Opioid-Related Disorders; Psychotropic Drugs; Stereoisomerism; Tabernaemontana	2019
Pharmacotherapy: Quest for the quitting pill. Nature, 2015, Jun-25, Volume: 522, Issue:7557 Topics: Animals; Behavior, Addictive; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Clinical Trials as Topic; Cocaine-Related Disorders; Counseling; Dopamine; Drug Discovery; Drug Industry; Humans; Ibogaine; Lobeline; Molecular Targeted Therapy; Naloxone; Naltrexone; Oligopeptides; Opioid-Related Disorders; Pleasure; Rats; Receptors, Nicotinic; Reward; Substance-Related Disorders; Tobacco Use Disorder; Vaccines; Vesicular Monoamine Transport Proteins	2015
Psychotropic complementary medicines. The British journal of psychiatry : the journal of mental science, 2006, Volume: 188 Topics: Humans; Ibogaine; Opioid-Related Disorders; Phytotherapy; Plant Extracts; Substance Withdrawal Syndrome	2006
Client and counselor attitudes toward the use of medications for treatment of opioid dependence. Journal of substance abuse treatment, 2007, Volume: 32, Issue:2 Topics: Adult; Ambulatory Care; Attitude of Health Personnel; Buprenorphine; Clonidine; Counseling; Culture; Female; Focus Groups; Heroin Dependence; Humans; Ibogaine; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Patient Admission; Patient Satisfaction; Peer Group; Psychotropic Drugs; Substance Withdrawal Syndrome; Treatment Outcome	2007
The ibogaine medical subculture. Journal of ethnopharmacology, 2008, Jan-04, Volume: 115, Issue:1 Topics: Data Collection; Hallucinogens; Humans; Ibogaine; Internet; Medicine, African Traditional; Opioid-Related Disorders; Substance Withdrawal Syndrome; Substance-Related Disorders	2008
18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats. Brain research, 1996, May-06, Volume: 719, Issue:1-2 Topics: Animals; Cerebellum; Cocaine; Dopamine; Female; Ibogaine; Limbic System; Morphine; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Self Administration; Tremor	1996
Ibogaine: a potent noncompetitive blocker of ganglionic/neuronal nicotinic receptors. Molecular pharmacology, 1997, Volume: 51, Issue:1 Topics: Animals; Carbachol; Dopamine; Ganglionic Blockers; Humans; Ibogaine; Male; Mice; Nicotinic Antagonists; Opioid-Related Disorders; PC12 Cells; Rats; Receptors, N-Methyl-D-Aspartate	1997